Expert Review of Endocrinology & Metabolism

Targeting kidney disease in type 1 diabetes: progress and promise

By Marcel H.A. Muskiet, David Z.I. Cherney

ReviewInterventions

The paper

Marcel H.A. Muskiet, David Z.I. Cherney

University Health Network

Expert Review of Endocrinology & Metabolism, 5 Aug 2026

doi.org/10.1080/17446651.2026.2714265 PubMed 42557690

Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk